Suraksha Diagnostic Ltd

BSE: 544293

total announcements

SURAKSHA.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 11 Nov 2026

Market Cap

₹1,825 Cr

P/E (TTM)

50.9

P/E (Forward)

35.8

EPS (TTM)

₹6.88

52W Low

₹224.10

52W High

₹360.00

Dividend Yield

0.14%

Price / Book

7.5

Debt / Equity

53.5

Revenue (TTM)

₹325 Cr

Gross Margin

88.41%

Operating Margin

21.80%

Announcements Discussion

BSECompany UpdateResults8h ago

Suraksha Diagnostic Ltd

Corrigendum to the Press Release-Interview published in the Times of India dated November 11,2026 regarding Financial Performance for the Quarter and Half Year ended September 30, 2026

Suraksha Diagnostic Ltd issued a corrigendum to correct errors in a press release regarding its financial performance for Q2 FY 2026-27. The corrections include changing the headline to 'Suraksha Diag sees over 100 Crore total income in Q2' and correcting the quarter-on-quarter net profit to ₹15 Crore.

Read more →📎 1 attachment

BSECompany UpdateResults8h ago

Suraksha Diagnostic Ltd

Newspaper Publication of Unaudited(Standalone and Consolidated) Financial Result of the Company for the Quarter and half year ended 30 September 2026

Suraksha Diagnostic Ltd published unaudited financial results for the quarter and half year ended September 30, 2026, in newspapers and on their website.

Read more →📎 1 attachment

BSEResultResults21h ago

Suraksha Diagnostic Ltd

Results-Financial Results for Quarter and Half Year ended 30 September 2026

Suraksha Diagnostic Ltd announced its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors. The results are available on the company's website and have been made available to the stock exchanges.

Read more →📎 1 attachment

BSECompany Update▲ PositiveResults1d ago

Suraksha Diagnostic Ltd

Press Release in respect of Unaudited(Standalone & Consolidated) Financial Results for the quarter ended 30th September 2026

Suraksha Diagnostic Ltd announced its unaudited financial results for the quarter ended 30th September 2026, with a 69% year-on-year growth in PAT and a 45% year-on-year growth in EBITDA. The company's total income grew by 26% year-on-year, and its EBITDA margin improved to 36.7% from 31.7% in the same period last year.

Read more →📎 1 attachment

BSEBoard MeetingResults1d ago

Suraksha Diagnostic Ltd

Outcome of Board Meeting held today i.e. 10th November 2026

Suraksha Diagnostic Ltd's board meeting held on November 10, 2026, approved the unaudited financial results for the quarter and half year ended September 30, 2026. The results are enclosed with the limited review report issued by the statutory auditors. The financial results are also available on the company's website.

Read more →📎 1 attachment

BSECompany UpdateResults5d ago

Suraksha Diagnostic Ltd

This is to inform you that the Company will host a Conference Call viz. 'Earnings Call' for the Analysts/Institutional Investors/ Organizations on Friday, 13th November, 2026 through Virtual/Digital means for the quarter and half year ended 30th September, 2026

Suraksha Diagnostic Ltd will host a conference call on November 13, 2026, to discuss their Q2 & H1 FY27 results. The call will be held at 11:00 AM IST and will feature company participants, including the Chairman, Joint Managing Directors, CFO, and Regional Business Head. The conference dial-in numbers and international toll-free numbers are provided.

Read more →📎 1 attachment

BSEBoard MeetingResults6d ago

Suraksha Diagnostic Ltd

Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2026 ,inter alia, to consider and approve SURAKSHA DIAGONISTIC LIMITED has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to inter-alia, consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half-year ended 30th September, 2026.

Suraksha Diagnostic Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2026 to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half-year ended 30th September, 2026.

Read more →📎 1 attachment

BSECompany Update3 Nov 2026

Suraksha Diagnostic Ltd

Intimation regarding change in the Corporate Office of Registrar to an issue and Share Transfer Agent(RTA) of the Company with effect from 01 December, 2026

Suraksha Diagnostic Ltd has informed about the change in the Corporate Office of Registrar to an Issue and Share Transfer Agent (RTA) with effect from 01 December, 2026.

Read more →📎 1 attachment

BSECompany UpdateRegulatory14 Oct 2026

Suraksha Diagnostic Ltd

The Board was aprised that the Company had received a notice dated 31-08-2026 from NSE, intimating that Company of non-Compliance with Regulation 31 of SEBI(LODR) Regulation 2015. The same was duly filed in preceeding day and payment of fine was duly made.

Suraksha Diagnostic Ltd received a notice from NSE for non-compliance with Regulation 31 of SEBI(LODR) Regulation 2015 due to a 1-day delay in submitting the Shareholding Pattern for the quarter ended 30th June, 2026. The fine of Rs. 2,360 has been paid.

Read more →📎 1 attachment

BSECompany Update14 Oct 2026

SURAKSHA DIAGNOSTIC LIMITED

SURAKSHA DIAGNOSTIC LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Suraksha Diagnostic Limited has informed BSE about the appointment of a new Company Secretary and Compliance Officer.